Unknown NA INTERVENTIONAL 2-arm NCT01265121

Sleep Apnea Syndrome on Acromegaly: Impact of the Treatment on the Carbohydrates Metabolism.

Sponsor: InCor Heart Institute

Conditions Acromegaly Insulin Resistance Obstructive Sleep Apnea

Interventions Continuous positive air pressure device (CPAP) External nasal dilator adhesive

Updated 5 times since 2017 Last updated: Dec 21, 2010 Started: Sep 30, 2009 Primary completion: Apr 30, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acromegaly and Insulin Resistance and is currently ongoing. InCor Heart Institute leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status NA
Jun 2018 — Jan 2021 [monthly]

Unknown Status NA
Jan 2017 — Jun 2018 [monthly]

Unknown Status NA

First recorded

Sep 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

InCor Heart Institute
University of Sao Paulo General Hospital

Data source: University of Sao Paulo General Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• São Paulo, Brazil